NSEAllotment of Securities4d ago · 5 Nov 2026, 10:26 pm
Allotment of Securities
Jubilant Pharmova Limited · JUBLPHARMA
✦ AI SummaryFundraise
Jubilant Pharmova Limited has informed the Exchange regarding allotment of 80,000 securities pursuant to Non Convertible Securities at its meeting held on November 05, 2026. The allotment is part of a private placement basis of Rs. 800 Crores.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jubilant Pharmova Limited has informed the Exchange regarding allotment of 80000 securities pursuant to Non Convertible Securities at its meeting held on November 05, 2026
Attachments (1)
📄pdf
Download →
JUBLPHARMA_05112026222548_JPM_-_Allotment_intimation_signed.pdf
View document text
November 05, 2026
BSE Limited National Stock Exchange of India Limited
Floor 25, P. J. Towers Exchange Plaza
Dalal Street, Fort Bandra Kurla Complex, Bandra (E)
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 530019 Symbol: JUBLPHARMA
Sub: Disclosure under Regulation 30 and other applicable provisions of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Allotment of
Non-Convertible Debentures (NCDs) on a private placement basis-Rs.800 Crores
Dear Sir/Madam,
In continuation to our disclosure dated October 12, 2026, with respect to the issuance of non-
convertible debentures on a private placement basis, we hereby inform you that the Finance
Committee of the Company at its meeting held today, i.e. Thursday, November 5, 2026, have approved
the allotment of 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs)
of the face value of Rs. 1,00,000 per debenture, issued at par, aggregating to Rs. 800 crore on private
placement basis to the successful bidders.
Date and time of occurrence of event: November 05, 2026, at 07:30 P.M. (IST).
The disclosure required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master
Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed
herewith as Annexure A.
This intimation is also being uploaded on the Company’s website at www.jubilantpharmova.com
This is for your information and record.
Thanking you,
Yours faithfully,
For Jubilant Pharmova Limited
Naresh Kapoor
Company Secretary
Encl: As above
Annexure A
No. Particulars Details
80,000 Unsecured, Rated,
Listed, Redeemable Non-
Convertible Debentures on
i. Size of the Issue private placement basis
having a face value of Rs.
1,00,000 each, aggregating to
Rs. 800 Crore
Whether proposed to be listed? If yes, name of the stock
ii. Yes, BSE Limited
exchange(s)
iii. Tenure of the Instrument 3 Years
Date of Allotment: 05
November 2026
iv. Date of Allotment and Date of Maturity
Date of Maturity: 05
November 2028
v. Coupon/Interest Offered 8.50% p.a.
Please refer to the Key
vi. Schedule of Payment of Coupon/Interest and Principal
Information Document.
vii. Charge/Security, if any, created over the assets None
Special right/interest/privileges attached to the instrument and
viii. Nil
changes thereof
Delay in payment of interest/principal amount for a period of more
ix. than three months from the due date or default in payment of NA
interest/principal
Details of any letter or comments regarding payment/non-payment
x. of interest, principal on due dates, or any other matter concerning Nil
the security and/or the assets along with comments thereon, if any
Details of redemption of debentures indicating the manner of As mentioned in Point Nos.
redemption iii and iv above